Show simple item record

dc.contributor.authorNiu, Sida
dc.contributor.authorBlack, Paul
dc.contributor.authorPadmanabhan, Priya
dc.descriptionA grant from the One-University Open Access Fund at the University of Kansas was used to defray the author's publication fees in this Open Access journal. The Open Access Fund, administered by librarians from the KU, KU Law, and KUMC libraries, is made possible by contributions from the offices of KU Provost, KU Vice Chancellor for Research & Graduate Studies, and KUMC Vice Chancellor for Research. For more information about the Open Access Fund, please see
dc.description.abstractIntroduction: Renal transplant is the most desired and cost-effective therapy for patients with end stage renal disease. While a lower urinary tract cause of end-stage renal disease (ESRD) is not an absolute contraindication to renal transplantation, appropriate vesical storage and drainage is imperative for survival and function of the graft. It is crucial to address and resolve any urological causes of renal failure prior to transplantation to prevent subsequent graft failure. Most patients can be managed with conservative measures such as intermittent self-catheterization, but select cases may require more aggressive intervention including bladder augmentation or urinary diversion to address a hostile bladder environment prior to transplantation. To our knowledge, this is the first report of a poorly compliant bladder noted during pre-transplant evaluation that was managed conservatively with intravesical botulinum injections leading to a successful transplantation.

Conclusion: We found through our experience that intravesical botulinum injections offers a conservative approach to increase bladder compliance and lower storage pressures thereby permitting safe renal transplantation. This management strategy can be employed in carefully selected patients who have failed oral anticholinergics and CIC, and wish to avoid bladder augmentation and urinary diversion. Careful follow-up is necessary to detect changes in urinary symptoms and bladder parameters, which may be a sign of possible botulinum failure necessitating the need to revisit more aggressive management options.
dc.rights© 2018 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND licenseen_US
dc.subjectAbnormal bladderen_US
dc.titleConservative management of hostile bladders with intravesical botulinum toxin for successful renal transplantationen_US
kusw.kuauthorNiu, Sida
kusw.oaversionScholarly/refereed, publisher versionen_US
kusw.oapolicyThis item meets KU Open Access policy criteria.en_US

Files in this item


This item appears in the following Collection(s)

Show simple item record

© 2018 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
Except where otherwise noted, this item's license is described as: © 2018 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license